LRRK2 Worthy Target of Research into Parkinson’s Therapies, Study Suggests

LRRK2 Worthy Target of Research into Parkinson’s Therapies, Study Suggests
A perspective article summarizes what researchers have learned so far on the role of LRRK2 mutations in the development of Parkinson’s disease, and recommends the enzyme as a target for therapy development. The report, “LRRK2 kinase in Parkinson’s disease,” was published in the journal Science. Although the vast majority of Parkinson’s cases are idiopathic, or of unknown cause, LRRK2 mutations ... read more
Source: Parkinson’s News TodayPublished on 2018-05-03By Ana Pena